Study guide
12.1 Risk Treatment, Mitigation, Monitoring, and Review
SEC Certification Examination Phase 1 General
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Corporate Structure & Capital Stock
1.1 Philippine Corporate Formation and Capital Structure 1.2 Common and Preferred Shares 1.3 Stockholder Rights and Corporate Actions 1.4 Corporate Debt and Fixed Income Instruments
2 Chapter 2: Financial Markets and Securities Products
2.1 Money Market and Capital Market Instruments 2.2 Collective Investment Schemes and Funds 2.3 Philippine Stock Exchange (PSE) Structure and Trading 2.4 Real Estate Investment Trusts (REITs) and Asset-Backed Securities
3 Chapter 3: Macroeconomic Principles and Monetary Policy
3.1 Gross Domestic Product, Inflation, and Business Cycles 3.2 Monetary Policy and the Bangko Sentral ng Pilipinas (BSP) 3.3 Fiscal Policy, National Debt, and Foreign Exchange 3.4 Philippine Financial Regulatory Architecture
4 Chapter 4: Financial Mathematics and Valuation Concepts
4.1 Time Value of Money and Interest Calculations 4.2 Bond Valuation and Yield Concepts 4.3 Equity Valuation Metrics and Financial Ratios 4.4 Investment Return, Risk Metrics, and Portfolio Principles
5 Chapter 5: The Securities Regulation Code (SRC) & Securities Registration
5.1 Legislative Framework and SEC Regulatory Powers 5.2 Definition and Scope of Securities 5.3 Mandatory Registration of Securities 5.4 Exempt Securities and Exempt Transactions
6 Chapter 6: Market Intermediaries & Trading Conduct
6.1 Registration of Brokers, Dealers, Associated Persons, and Salesmen 6.2 Duties and Ethical Standards of Market Professionals 6.3 Supervision and Compliance Organization 6.4 Books, Records, and Customer Account Handling
7 Chapter 7: Market Manipulation, Insider Trading & Public Disclosures
7.1 Prohibited Acts and Market Manipulation 7.2 Insider Trading and Unlawful Disclosures 7.3 Tender Offer Rules, Proxy Solicitation, and Periodic Reports
8 Chapter 8: Principles of Corporate Governance & Board Oversight
8.1 Evolution and Governance Framework in the Philippines 8.2 Board Composition, Roles, and Fiduciary Duties 8.3 Independent Directors and Term Limits 8.4 Board Committees and Special Responsibilities
9 Chapter 9: Internal Controls, Disclosure & Shareholder Rights
9.1 Internal Control System and Internal Audit Function 9.2 Related Party Transactions (RPT) Policy and Governance 9.3 Corporate Transparency and Timely Disclosure 9.4 Rights of Shareholders and Stakeholder Engagement
10 Chapter 10: Risk Concepts and Categories
10.1 Risk, Uncertainty, and Objectives 10.2 Financial Risks: Market, Credit, and Liquidity 10.3 Non-Financial Risks: Operational, Strategic, and Reputational
11 Chapter 11: Risk Management Process
11.1 Risk Management: Coordinated Direction and Control 11.2 Risk Identification 11.3 Risk Analysis and Evaluation
12 Chapter 12: Risk Treatment and Hedging
12.1 Risk Treatment, Mitigation, Monitoring, and Review 12.2 Hedging: Purpose and Exposure Identification 12.3 Hedging Strategies and Instruments 12.4 Integrated Risk Scenarios and Review
13 Chapter 13: AML Legal Framework & Institutional Governance
13.1 Anti-Money Laundering Act of 2001 (AMLA) and Amendments 13.2 Anti-Money Laundering Council (AMLC) Powers and Structure 13.3 Money Laundering Offenses and the Three Stages 13.4 Compliance Framework and Money Laundering Prevention Program (MLPP)
14 Chapter 14: Customer Due Diligence, Reporting & Record Keeping
14.1 Customer Due Diligence (CDD) and Know-Your-Customer (KYC) 14.2 Politically Exposed Persons (PEPs) and High-Risk Relationships 14.3 Covered and Suspicious Transaction Reporting 14.4 Record Keeping, Freezing of Assets, and Penalties
12.1 Risk Treatment, Mitigation, Monitoring, and Review
Key Takeaways Explain This Topic AI
Risk treatment selects and implements options that change risk; mitigation usually reduces likelihood or consequence.
Avoid, reduce, share or transfer, and retain are distinct responses, and transfer rarely removes accountability or all exposure.
Treatment plans need owners, resources, due dates, measures, and explicit residual-risk decisions.
Monitoring tracks indicators and control performance continuously or periodically; review reassesses design and suitability.
Incidents, near misses, limit breaches, regulatory changes, and deteriorating indicators trigger reassessment.
Last updated: October 2026
12.1 Risk Treatment, Mitigation, Monitoring, and Review
Risk treatment is the process of selecting and implementing options to modify risk. Mitigation commonly means reducing likelihood, consequence, or both, but treatment is broader. Management may avoid an activity, change it, share exposure, accept residual risk, or pursue an opportunity with safeguards.
Treatment choices
- Response Meaning Example
- Avoid Do not start or discontinue the risk-creating activity Decline an unlawful product structure
- Reduce likelihood Make the event less probable Strong authentication and access review
- Reduce consequence Limit harm if it occurs Backups, capital buffers, and recovery capability
- Share or transfer Allocate defined financial consequences to another party Insurance, indemnity, or hedge
- Retain Knowingly accept within authority and criteria Monitor a small exposure within tolerance
Treatment can create new risk. Outsourcing may lower internal processing burden but adds vendor and concentration risk. Insurance adds exclusions, deductibles, limits, and insurer credit risk. A hedge can introduce basis, counterparty, liquidity, and rollover risk. The full risk profile must be reassessed after selection.
Selecting a treatment
Selection considers effectiveness, legal requirements, cost and benefit, feasibility, time to implement, stakeholder effects, and risk appetite. Cost-benefit analysis does not permit violation of a mandatory rule. Where treatment is not immediately complete, interim controls and escalation may be needed.
Controls may be:
- preventive , stopping an event before it occurs;
- detective , identifying an event or error quickly;
- corrective , restoring conditions and preventing recurrence;
- directive , setting expected conduct; or
compensating , providing an alternative when the preferred control is unavailable.
A balanced design often uses more than one type. Approval limits are preventive; exception reports are detective; reversal and remediation are corrective. Multiple controls provide defense only when they are sufficiently independent and actually operate.
Treatment plan and residual acceptance
A credible plan specifies the risk, selected response, actions, responsible owner, resources, milestones, completion date, dependencies, success measures, and reporting. The owner of the action may differ from the owner accountable for the risk.
After treatment, residual risk is reassessed. Acceptance must be made by a person with appropriate authority and documented at the right level. A business manager cannot accept exposure beyond board-approved appetite or waive a legal requirement. Temporary exceptions need a rationale, expiry date, compensating controls, and review.
Monitoring
Monitoring observes whether risk levels, controls, limits, and treatments behave as expected. Sources include key risk indicators (KRIs), key performance indicators, limit utilization, exception reports, reconciliations, loss and incident data, complaints, audit findings, vendor reports, market data, and regulatory developments.
A KRI should have a clear definition, data owner, frequency, threshold, escalation path, and link to a risk. A threshold is useful when it provides time to act. A measure that reports failure only after irreversible harm is a lagging indicator; it may need a leading companion such as staff turnover, unresolved vulnerabilities, or concentration growth.
Review and assurance
Review asks whether objectives, context, assumptions, criteria, risk assessment, and treatments remain suitable. Reviews occur on a schedule and after triggers such as a major incident, near miss, product launch, acquisition, law change, control failure, unusual market move, or repeated breach.
Control owners perform routine checks; risk and compliance functions monitor and challenge; internal audit gives independent assurance. An audit opinion is not a substitute for management's continuous responsibility.
Incident and near-miss learning
An incident review should contain the event chronology, immediate containment, root cause, control failures, impact, required notification, remediation, owner, and verification of closure. A near miss did not create the final harm but could have under slightly different conditions. Treating near misses as “no loss, no problem” discards valuable warning evidence.
Feedback loop
Monitoring and review return information to every earlier stage. A rising indicator may reveal a new risk, change likelihood, show that a control is ineffective, or require different treatment. The process is cyclical:
identify → analyze → evaluate → treat → monitor and review → reassess .
Exam method
Do not assume transfer eliminates risk or responsibility. Choose treatments that address the actual cause or consequence, then assess new and residual risks. Distinguish monitoring—ongoing observation—from review—periodic or triggered reconsideration of suitability and effectiveness.
Control Design and Monitoring Evidence
Each treatment should specify an owner, completion date, resources, intended effect, and verification method. Preventive controls reduce the chance of an event; detective controls reveal it; corrective controls limit damage and restore operations. A control described only as “management review” is incomplete unless the reviewer, inputs, frequency, escalation thresholds, and retained evidence are clear. Monitoring should track both implementation and outcome. Closing an action because a procedure was issued is premature if breaches continue. Residual risk is reassessed after the control operates, and material changes or failed indicators return the exposure to analysis, evaluation, and possibly a different treatment.